These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 36523702)

  • 1. Psychotic Cannabis Withdrawal: A Clinical Case.
    Ramos B; Santos Martins AF; Lima Osório ES
    Cureus; 2022 Nov; 14(11):e31465. PubMed ID: 36523702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cannabis withdrawal in chronic, frequent cannabis smokers during sustained abstinence within a closed residential environment.
    Lee D; Schroeder JR; Karschner EL; Goodwin RS; Hirvonen J; Gorelick DA; Huestis MA
    Am J Addict; 2014; 23(3):234-42. PubMed ID: 24724880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nabilone therapy for cannabis withdrawal presenting as protracted nausea and vomiting.
    Lam PW; Frost DW
    BMJ Case Rep; 2014 Sep; 2014():. PubMed ID: 25246463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cannabis withdrawal induced brief psychotic disorder: a case study during the national lockdown secondary to the COVID-19 pandemic.
    Marín J; Pérez de Mendiola X; Fernández S; Chart JP
    J Addict Dis; 2021; 39(4):579-584. PubMed ID: 33884940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolonged cannabis withdrawal in young adults with lifetime psychiatric illness.
    Schuster RM; Fontaine M; Nip E; Zhang H; Hanly A; Evins AE
    Prev Med; 2017 Nov; 104():40-45. PubMed ID: 28242263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case of withdrawal psychosis from internet addiction disorder.
    Paik A; Oh D; Kim D
    Psychiatry Investig; 2014 Apr; 11(2):207-9. PubMed ID: 24843379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabidiol for the treatment of cannabis withdrawal syndrome: a case report.
    Crippa JA; Hallak JE; Machado-de-Sousa JP; Queiroz RH; Bergamaschi M; Chagas MH; Zuardi AW
    J Clin Pharm Ther; 2013 Apr; 38(2):162-4. PubMed ID: 23095052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mental health functioning and severity of cannabis withdrawal among medical cannabis users with chronic pain.
    Perron BE; Holt KR; Yeagley E; Ilgen M
    Drug Alcohol Depend; 2019 Jan; 194():401-409. PubMed ID: 30500688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cannabis and psychopathology : update 2004.
    Grover S; Basu D
    Indian J Psychiatry; 2004 Oct; 46(4):299-309. PubMed ID: 21206788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cannabis and psychosis: search of a causal link through a critical and systematic review].
    Le Bec PY; Fatséas M; Denis C; Lavie E; Auriacombe M
    Encephale; 2009 Sep; 35(4):377-85. PubMed ID: 19748375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cannabis use disorders and psychiatric comorbidities].
    Dervaux A
    Rev Prat; 2018 Jun; 68(6):670-674. PubMed ID: 30869262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective assessment of cannabis withdrawal in adolescents with cannabis dependence: a pilot study.
    Milin R; Manion I; Dare G; Walker S
    J Am Acad Child Adolesc Psychiatry; 2008 Feb; 47(2):174-179. PubMed ID: 18176332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypocalcemia-Induced Reversible Psychosis.
    Hall A; Bin Farooq T; Alcaraz R
    Cureus; 2022 Jan; 14(1):e20874. PubMed ID: 35145781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Letter to the Editor: Depression As The First Symptom Of Frontal Lobe Grade 2 Malignant Glioma.
    Nazlı ŞB; Sevindik M
    Turk Psikiyatri Derg; 2022; 33(2):143-145. PubMed ID: 35730515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atypical course in severe catatonic schizophrenia in a cannabis-dependent male adolescent: a case report.
    Håkansson A; Johansson BA
    J Med Case Rep; 2015 Sep; 9():200. PubMed ID: 26388066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cannabis withdrawal syndrome in patients with cannabis dependence only, and in patients with cannabis and opioid dependence].
    Vorspan F; Guillem E; Bloch V; Bellais L; Sicot R; Noble F; Lepine JP; Gorelick DA
    Encephale; 2011 Sep; 37(4):266-72. PubMed ID: 21981886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Motivational interviewing for cannabis users with psychotic disorders].
    Bonsack C; Montagrin Y; Favrod J; Gibellini S; Conus P
    Encephale; 2007 Oct; 33(5):819-26. PubMed ID: 18357854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Schizophrenia and amphetamine dependence. A case report].
    Dervaux A; Krebs MO; Laqueille X
    Encephale; 2005; 31(2):247-50. PubMed ID: 15959451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Withdrawal symptoms do not predict relapse among subjects treated for cannabis dependence.
    Arendt M; Rosenberg R; Foldager L; Sher L; Munk-Jørgensen P
    Am J Addict; 2007; 16(6):461-7. PubMed ID: 18058411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabis as a risk factor for psychosis: systematic review.
    Semple DM; McIntosh AM; Lawrie SM
    J Psychopharmacol; 2005 Mar; 19(2):187-94. PubMed ID: 15871146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.